国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
依达拉奉联合常规治疗对急性脑梗死患者神经功能的影响
Influence of Edaravone plus Regular Treatment on Neural Function in Patients with Acute Cerebral Infarction
  
DOI:
中文关键词:  依达拉奉  急性脑梗死  神经功能  超氧化物歧化酶  神经元特异性烯醇化酶  丙二醛
英文关键词:Edaravone  Acute cerebral infarction  Neural function  Superoxide dismutase  Neuron specific enolization enzyme  Malondialdehyde
基金项目:2012丽水市公益性应用技术项目(编号:2012JYZB16)
作者单位
吴燕 曾娟娟 陈庆丽 徐俊龙 ①丽水市人民医院重症医学科(浙江丽水 323000)。 
摘要点击次数: 1384
全文下载次数: 1029
中文摘要:
      摘 要 目的:观察依达拉奉联合常规治疗对急性脑梗死患者神经功能的影响。方法:144例急性脑梗死患者随机分为观察组(n=72)和对照组(n=72),对照组给予常规治疗,观察组在常规治疗基础上加用依达拉奉,疗程2周。比较两组患者治疗前后的血清超氧化物歧化酶(SOD)、血清丙二醛(MDA)和神经元特异性烯醇化酶(NSE)水平变化,根据美国国立卫生研究院卒中量表(NIHSS)评定两组神经功能缺损。结果:治疗后两组的NIHSS评分均较治疗前明显降低(P<0.05),观察组治疗后评分明显低于对照组(P<0.05)。治疗后两组患者血清SOD水平均较治疗前明显升高,MDA和NSE水平则明显降低(P<0.05);且治疗后两组患者SOD、MDA和NSE水平比较,差异有统计学意义(P<0.05)。两组药品不良反应发生率比较,差异无统计学意义(P>0.05)。结论:依达拉奉能明显改善急性脑梗死患者的神经功能,其作用机制与清除自由基、降低神经元特异性烯醇化酶有关。
英文摘要:
      ABSTRACT Objective: To observe the effect of edaravone on neural function in patients with acute cerebral infarction. Methods:144 cases with acute cerebral infarction were randomly divided into observation group (n=72) and control group (n=72). The control group were treated with conventional therapy, and the observation group were given edaravone additionally for 2 weeks. The levels of serum superoxide dismutase (SOD), serum malondialdehyde (MDA) and neuron specific enolization enzymes (NSE) of the two groups were compared. The neurologic impairment of the two groups were evaluated by National Institute of Health stroke scale (NIHSS).Results:The NIHSS scores in both the two groups were lower after treatment than baseline(P<0.05), and the observation group changed more than control group (P<0.05). After treatment in both the two groups the levels of SOD were increased, the levels of MDA and NSE were decreased, which were all produced siginificant differences (P<0.05); furthermore, the observation group changed more than control group in all the three indicators (P<0.05). The incidences of adverse drug reactions showed no significant difference in two groups(P>0.05). Conclusion:Edaravone could obviously improve neural function in patients with acute cerebral infarction, which might be related to scavenging free radicals and reducing neuron specificity enolization related enzymes.
查看全文  查看/发表评论  下载PDF阅读器
关闭